BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1956787)

  • 1. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes.
    Louis-Plence P; Moreno CS; Boss JM
    J Immunol; 1997 Oct; 159(8):3899-909. PubMed ID: 9378978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
    Ono SJ; Song Z
    J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
    Rousseau P; Paul P; O'Brien M; Dausset J; Carosella ED; Moreau P
    Hum Immunol; 2000 Nov; 61(11):1132-7. PubMed ID: 11137218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.
    Reith W; Kobr M; Emery P; Durand B; Siegrist CA; Mach B
    J Biol Chem; 1994 Aug; 269(31):20020-5. PubMed ID: 8051086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
    Durand B; Kobr M; Reith W; Mach B
    Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer.
    Westerheide SD; Boss JM
    Nucleic Acids Res; 1999 Apr; 27(7):1635-41. PubMed ID: 10075994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC transcriptional mutants are defective in higher order complex formation.
    Riley JL; Boss JM
    J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
    Hasegawa SL; Riley JL; Sloan JH; Boss JM
    J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.
    Jabrane-Ferrat N; Fontes JD; Boss JM; Peterlin BM
    Mol Cell Biol; 1996 Sep; 16(9):4683-90. PubMed ID: 8756625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory factor-X binding to mutant HLA-DRA promoter sequences.
    Hasegawa SL; Sloan JH; Reith W; Mach B; Boss JM
    Nucleic Acids Res; 1991 Mar; 19(6):1243-9. PubMed ID: 1903200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the X2 box in activated transcription from the DRA promoter in B cells.
    Setterblad N; Peterlin BM; Andersson G
    Immunogenetics; 1997; 46(4):318-25. PubMed ID: 9218534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X box-like sequences in the MHC class II region maintain regulatory function.
    Gomez JA; Majumder P; Nagarajan UM; Boss JM
    J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotides specific for regulatory factor RFX-1 inhibit inducible but not constitutive expression of all major histocompatibility complex class II genes.
    Siegrist CA; Mach B
    Eur J Immunol; 1993 Nov; 23(11):2903-8. PubMed ID: 8223867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
    Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
    J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.